Search research articles
Contact Us
Filters
Showing results (181-190 of 184) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 184 results.
Critical Pathways in Cardiology
|
May 23, 2023
Impact of HEART Score Decision Aid on Coronary Computed Tomography Angiography Utilization and Diagnostic Yield in the Emergency Department
Brian J McMahon, Pragati Shrestha, Henry C Thode, et al.
The American Journal of Emergency Medicine
|
January 22, 2017
Missed myocardial infarctions in ED patients prospectively categorized as low risk by established risk scores
A J Singer, M P Than, S Smith, et al.
The Journal of Emergency Medicine
|
December 14, 2020
Comparison of the ST-Elevation Myocardial Infarction (STEMI) vs. NSTEMI and Occlusion MI (OMI) vs. NOMI Paradigms of Acute MI
H Pendell Meyers, Alexander Bracey, Daniel Lee, et al.
ESMO Open
|
June 5, 2024
Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B
F Marmé, M Martin, M Untch, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 184) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 184 results.
Critical Pathways in Cardiology
|
May 23, 2023
Impact of HEART Score Decision Aid on Coronary Computed Tomography Angiography Utilization and Diagnostic Yield in the Emergency Department
Brian J McMahon, Pragati Shrestha, Henry C Thode, et al.
The American Journal of Emergency Medicine
|
January 22, 2017
Missed myocardial infarctions in ED patients prospectively categorized as low risk by established risk scores
A J Singer, M P Than, S Smith, et al.
The Journal of Emergency Medicine
|
December 14, 2020
Comparison of the ST-Elevation Myocardial Infarction (STEMI) vs. NSTEMI and Occlusion MI (OMI) vs. NOMI Paradigms of Acute MI
H Pendell Meyers, Alexander Bracey, Daniel Lee, et al.
ESMO Open
|
June 5, 2024
Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B
F Marmé, M Martin, M Untch, et al.
Page
of 19